1150PRecombinant humanized anti-PD-1 monoclonal antibody (JS001) in patients with refractory/metastatic nasopharyngeal carcinoma: Preliminary results of an open-label phase II clinical study. (23rd October 2018) - Xu, R; Wang, F H; Feng, F J; Li, Q; Xu, N; Hu, X C; Liao, W J; Jiang, Y; Lin, X; Zhang, Q Y; Yuan, X L; Huang, H X; et al.